medigraphic.com
ISSN 1527-3172 (Digital)

2014, Número 1

<< Anterior Siguiente >>

MEDICC Review 2014; 16 (1)


Platelet serotonin concentration and clinical status in alcohol withdrawal syndrome, preliminary results

Llinás CSG, Caballero MAJ, Peñalver GJC, Valdés VR

Idioma: Ingles.
Referencias bibliográficas: 34
Paginas: 37-41
Archivo PDF: 183.61 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Health Organization. Global status report on non-communicable diseases [Internet]. Geneva: World Health Organization; 2010 [cited 2013 Sep 26]. 164 p. Available from: http://www.who .int/nmh/publications/ncd_report_full_en.pdf

  2. Sánchez JF, Álvarez P, Rodríguez JJ. Psychiatric disorders associated with alcoholism: 2 year follow-up of treatment. Actas Esp Psiquiatr. 2012 May–Jun;40(3):129–35.

  3. Chen CY, Storr CL, Anthony JC. Early-onset drug use and risk for drug dependence problems. Addict Behav. 2009 Mar;34(3):319–22.

  4. Freeman WM, Vrana KE. Future prospect for biomarkers of alcohol consumption and alcoholinduced disorder. Acohol Clin Exp Res. 2010 Jun;34(6):946–54.

  5. Johnson BA. Role of serotoninergic system in the neurobiology of alcoholism. CNS Drugs. 2004;18(15):1105–18.

  6. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Ann Rev Med. 2009;60:355–66.

  7. Aguayo LG, Peoples RW, Yeh HH, Yevenes GE. GABA (A) receptors as molecular sites of ethanol action. Direct or indirect actions? Curr Top Med Chem. 2002 Aug;2(8):869–85.

  8. Bajo M, Madamba SG, Lu X, Sharkey LM, Bartfai T, Siggins GR. Receptor subtype-dependent galanin actions on γ-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala. Addict Biol. 2012 Jul;17(4):694–705.

  9. Schuckit MA. Alcohol-use disorders. Lancet. 2009 Feb 7;373(9662):492–501.

  10. Nenadic-Sviglin K, Nedic G, Nikolac M, Kozaric- Kovacic D, Stipcevic T, Muck Seler D, et al. Suicide attempt, smoking, comorbid depression, and platelet serotonin in alcohol dependence. Alcohol. 2011 May;45(3):209–16.

  11. Mukherjee S, Das SK, Vaidyanathan K, Vasudevan DM. Consequences of alcohol consumption on neurotransmitters—An overview. Curr Neurovasc Res. 2008 Nov;5(4):266–72.

  12. Lovinger DM. The role of serotonin in alcohol’s effects on the brain. Curr Separations. 1999;18(1):23–8.

  13. Hughes JR. Alcohol withdrawal seizures. Epilepsy Behav. 2009 Jun;15(2):92–7.

  14. Martín MM, Pastor I, Laso F. Farmacogenética en el tratamiento del alcoholismo. Act Farmacol Terapéutica. 2012;10(3):159–60. Spanish.

  15. Bayard M, McIntyre J, Hill KR, Woodside JJr. Alcohol withdrawal syndrome. Am Fam Physician. 2004 Mar;69(6):1443–50.

  16. Veray R, Vekaria S, Eisenberg S. Treatment of the hospitalized alcohol-dependent patient with alcohol withdrawal syndrome. Internet J Int Med [Internet]. 2009 [cited 2013 Sep 26];8(1). Available from: http://ispub.com/IJIM/8/1/6232#

  17. Reilly TM. Physiological dependence on, and symptoms of withdrawal from chlormethiazole. Brit J Psychiatry. 1976 Apr;128:375–8.

  18. Kleber HD, Weiss RD, Anton RF Jr, George TP, Greenfi eld SF, Kosten TR, et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007 Apr;164(4 Suppl):5–123.

  19. Cortes C, Galindo F, Galicia S, Flores A. GABA: ¿dualidad funcional? Transición durante el neurodesarrollo. Rev Neurol. 2011 Jun;52(11):665– 75. Spanish.

  20. Möhler H. GABAA receptor diversity and pharmacology. Cell Tissue Res. 2006 Nov;326(2):505–16.

  21. Paton C. Benzodiazepines and disinhibition: a review. The Psychiatrist. 2002;26:460–2.

  22. Lesch KP, Wolozin BL, Murphy DL, Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem. 1993 Jun;60(6):2319–22.

  23. Sneddon JM. Blood platelets as a model for monoamine-containing neurones. Prog Neurobiol. 1973;1(2):151–98.

  24. Javors M, Tiouririne M, Prihoda T. Platelet serotonin uptake is higher in early-onset than in late-onset alcoholi cs. Alcohol Alcohol. 2000 Jul– Aug;35(4):390–3.

  25. Arranz B, Rosel P, Sarró S, Zaldivar E, Cano R, Navarro MA, et al. Platelet serotonergic binding sites in alcohol-dependent patients. Alcohol Alcohol. 1999 Sep–Oct;34(5):726–32.

  26. Bailly D, Vignau J, Racadot N, Beuscart R, Servant D, Parquet PJ. Platelet serotonin levels in alcoholic patients: changes related to physiological and pathological factors. Psychiatry Res. 1993 Apr;47(1):57–88.

  27. Bailly D, Vignau J, Lauth B, Racadot N, Beuscart R, Servant D, et al. Platelet serotonin decrease in alcoholic patients. Acta Psychiatr Scand. 1990 Jan;81(1):68–72.

  28. Alvarez JC, Gluck N, Arnulf I, Quintin P, Leboyer M, Pecquery R, et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fl uoxetine. Clin Pharmacol Ther. 1999 Dec;66(6):617–24.

  29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSMIV. 4th ed. Washington: American Psychiatric Association; 2001.

  30. Easton C, Meza E, Mager D, Ulüg B, Kilic C, Gögüs A, et al. Test-retest reliability of the schedules for clinical assessment in neuropsychiatry (SCAN). Drug Alcohol Depend. 1997 Sep 25;47(3):187–94.

  31. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989 Nov;84(11):1353–7.

  32. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–75.

  33. Trevisan L, Boutros N, Petrakis IL, Krystal JH. Complications of alcohol withdrawal, pathophysiological insights. Alcohol Health & Res World. 1998;22(1):61–6.

  34. Ruusa J, Bergman B. Sex hormones and alcohol withdrawal: does a good supply of testosterone prevent serious symptoms during detoxifi cation?Alcohol. 1996 Mar–Apr;13(2):139–45.




2020     |     www.medigraphic.com